No registrations found.
ID
Source
Health condition
Goal: to determine overall survival of AML patients in the province of Friesland (NL) and to determine whether overall survival is dependent on the factors mentioned. Early death will also be determined.
Sponsors and support
Intervention
Outcome measures
Primary outcome
none
Secondary outcome
none
Background summary
Acute myeloid leukemia (AML) is a heterogeneous hematopoietic stem cell disease characterised by a proliferation of myeloblasts in the bone marrow. The incidence is 3 to 4 per 100.000. AML is a heterogeneous disease with may subtypes showing large differences in age, comorbidity, performance status and treatment of the patient.
Study objective
The hypothesis: the overall survival of AML patients is influenced by AML type, age, genetic aberrancies, comorbidity and performance status of the patient as well as type of treatment.
Study design
31-12-2017
Intervention
none
Inclusion criteria
retrospective observational population-based; all patients in Friesland
Exclusion criteria
retrospective observational population-based; all patients in Friesland
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| NTR-new | NL5925 |
| NTR-old | NTR6105 |
| Other | VZ-NI-OTHER-Hemobase-007339 : RTPO980a |